Viatris Reveals Generic Rybelsus Candidate As Part Of Continued Complex Push
Eight Complex Programs Are At Various Stages Of Development
Recently-formed Viatris is looking to build on the success of several high-margin complex generics launches, including versions of Advair and Copaxone, by developing further candidates, including rivals to Novo Nordisk’s Rybelsus (semaglutide) and Victoza (liraglutide).
